There have been plenty of incidents like this on DXM as well actually. Dextroverse is full of similar stories, stabbing, grisly suicide attempt, rape of an elderly woman after forcing entry to her house and the like.
It may be relevant to reiterate Solipsis' earlier point about methoxphenidine's diphenyl structure in relation to dizocilpine (MK801), which according to its wikipedia page
and
i.e. it's probably most prudent to not use MXP at any rate approaching a regular frequency, or in high doses.
Can Solipsis, or anybody confirm or elaborate on these similarities beyond what hamhurricane offers in this earlier quote?
I think these are good points to combine: putting this in perspective, other dissociative drugs than MXP may carry similar risks, but mostly if taken up to the same level by comparison, via frequency or high dosage. Diphenidine and MXP apparently are just more pronounced this way and from the sounds of other people's experience and my brief trial with diphenidine there doesn't seem to be a more reasonable level of dissociative experience, or if there is, a lot of people are overshooting that range. Don't get me wrong, I think compounds like 3-MeO-PCP and 3-MeO-PCE are also very tricky and the amnesia factor is important for incidents where people temporarily lose themselves.
On dextroverse aren't there many avid DXM fans who take it up to upper plateaus? I believe that there is a significant number of people deterred by side-effects who don't entirely push the envelope... and with ketamine there is a lot more anaesthesia and less monoaminergic component. I may be wrong especially about the DXM, since I don't know the culture that well, only mostly that there is a pretty big one.
So IMO dissociatives should be used with responsibility and moderation and can obviously be very dangerous if not.
But additionally: some of the more novel and highly potent dissociatives may offer a shortcut to rather extreme states and maybe this makes it more difficult for people to watch their limits?
@psoodonym:
First of all, SAR is notoriously tricky so there are no guarantees here. But diphenidine and the analogues are modelled on the pharmacophore a number of dissociatives share, check the structures:
http://www.deepdyve.com/lp/elsevier...f-1-2-diphenylethylamine-and-1-1-2-VTv7PPJT5D
MXP's methoxy group is actually placed on the same aromatic ring (labeled A here) as the methoxy group on methoxetamine, only on MXP the substitution is ortho (2-) and on MXE it is meta (3-). By the way ham is partially right that the numbering system does not carry over, strictly speaking. The name 2-Meo-diphenidine is wrong because the true 2-position is on the backbone of the diphenidine molecule, the carbon directly on the right of the aromatic ring labeled B. The correct name would be '2-MeO-diphenidine, or it might require two or three apostrophies, I am not a 100% certain in which order the two phenylrings and the piperidine ring follow.
I can't really speculate much about diphenidine analogue development, but borrowing from other dissociative structures and generalizing the pharmacophore I think chemists have something to go on when they design analogues and add substitutions. Not only can wins and fails of MK-801 analogue design be used but also results from arylcyclohexylamines.
Still, you can't really fully rely on hybridized SAR like this apart from using it as mere guideline, and ham says that MK-801 is relatively optimized... but diphenidine isn't necessarily.